1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA PEA15 CTRPv2 pan-cancer AAC -0.1 0.01
mRNA SPDYE16 CTRPv2 pan-cancer AAC 0.088 0.01
mRNA SERAC1 CTRPv2 pan-cancer AAC -0.093 0.01
mRNA ALOX12 CTRPv2 pan-cancer AAC -0.087 0.01
mRNA CARD19 CTRPv2 pan-cancer AAC 0.092 0.01
mRNA NAPRT CTRPv2 pan-cancer AAC 0.095 0.01
mRNA LRRC36 CTRPv2 pan-cancer AAC -0.088 0.01
mRNA KIAA1191 CTRPv2 pan-cancer AAC -0.1 0.01
mRNA STX5 CTRPv2 pan-cancer AAC -0.091 0.01
mRNA RIPK4 CTRPv2 pan-cancer AAC 0.098 0.01
Download CSV